Due to the phenotypic similarity of CD4+CD25+ cutaneous T cell lymphoma cells and CD4+CD25+ TREG cells, Ontak was tested in many cancers. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.